Dr. LeBlanc on Incorporating Palliative Care in the Treatment of Hematologic Malignancies

Video

Thomas W. LeBlanc, MD, MA, medical oncologist, palliative care physician, Duke Cancer Institute, gives advice on incorporating palliative care in the treatment of hematologic malignancies.

Thomas W. LeBlanc, MD, MA, medical oncologist, palliative care physician, Duke Cancer Institute, gives advice on incorporating palliative care in the treatment of patients with hematologic malignancies.

LeBlanc says that medical oncologists should consider actively engaging palliative care specialists in the management of patients with hematologic malignancies.

It has been shown that patients undergoing stem cell transplant who were randomized to early concurrent palliative care experienced significant benefits in symptom management, quality of life, and a reduction in post-traumatic stress and depression.

Related Videos
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD